Alnylam Pharmaceuticals Inc., of Cambridge, Mass., appointed Olivier Brandicourt to its board, effective March 2, 2020.

Equillium Inc., of La Jolla, Calif., appointed Maple Fung vice president of clinical development and Matthew Ritter vice president of corporate development.

Immunomedics Inc., of Morris Plains, N.J., appointed Robert W. Azelby to its board.

No Comments